Life Sciences - Page 44 - Research Triangle Regional Partnership

World Health Organization picks NCSU to help combat antibiotic-resistant bacteria

February 19, 2020

RALEIGH – The World Health Organization (WHO) has designated North Carolina State University’s Department of Population Health and Pathobiology as…

UNC researchers implicate gene in DNA errors in aggressive breast cancer

February 19, 2020

CHAPEL HILL – A hallmark of triple negative breast cancer, an aggressive breast cancer type, is the accumulation of errors…

A closeup of a pipette carefully placing red droplets into a petri dish.

Booming Triangle sector has nearly 24,500 workers, up 4 percent year-over-year – List Insights

February 19, 2020

One of the Triangle’s more prominent subsets in its burgeoning life sciences is contract research. And this area has become…

Why this company picked NC for a $110 million investment

February 19, 2020

A San-Fransisco gene therapy company knew it wanted a new base outside of California, and it says the Triangle is…

Study: Thousands of biopharma jobs coming to NC by 2024; average wage $97,575

February 18, 2020

RESEARCH TRIANGLE PARK – North Carolina is widely known for its job-ready biopharma manufacturing workforce. And the newly published 2020…

Biotech startup Arrevus receives FDA orphan drug designation for cystic fibrosis treatment

February 18, 2020

RALEIGH — Biotech startup Arrevus is one step closer to potentially extending the lifespans of those living with cystic fibrosis…

The Triangle’s big slice of NC bio/pharma pie – List Insights

February 18, 2020

The life sciences industry is no doubt big business in North Carolina with more than 735 bioscience companies and a…

Duke spinout Polarean exceeds expectations with lung-imaging trial, seeks meeting with FDA

February 7, 2020

A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised…

NC State, biopharma company developing gene therapy for asthma

February 6, 2020

NEW YORK, N.Y. — Biopharmaceutical company Hoth Therapeutics has tapped NC State to collaborate and carry out a preclinical study…